Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $744.69 billion, total revenue of $168.59 billion and a weighted average PE ratio of 46.47.
Market Cap
744.69B
Revenue
168.59B
Profits
16.03B
PE Ratio
46.47
Profit Margin
9.51%
Dividend Yield
0.21%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 202.81B | -1.27% | 2,022,079 | 44.56B |
| 2 | DHR | Danaher Corporation | 155.34B | 1.43% | 4,405,342 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 51.63B | 1.05% | 487,397 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 36.49B | 1.18% | 2,123,696 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 30.94B | -5.30% | 3,646,526 | 16.31B |
| 6 | NTRA | Natera, Inc. | 29.28B | 0.51% | 927,185 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.46B | 1.41% | 144,929 | 4.03B |
| 8 | LH | Labcorp Holdings Inc. | 23.59B | 3.83% | 1,017,391 | 13.77B |
| 9 | DGX | Quest Diagnostics Incorporated | 22.84B | 7.37% | 2,294,815 | 11.04B |
| 10 | EXAS | Exact Sciences Corporation | 19.61B | 0.03% | 2,020,159 | 3.08B |
| 11 | WAT | Waters Corporation | 19.47B | -0.34% | 3,724,827 | 3.17B |
| 12 | ILMN | Illumina, Inc. | 18.23B | 1.77% | 2,442,794 | 4.34B |
| 13 | GH | Guardant Health, Inc. | 13.53B | -0.31% | 1,054,965 | 902.57M |
| 14 | MEDP | Medpace Holdings, Inc. | 12.62B | -15.90% | 1,031,132 | 2.36B |
| 15 | RVTY | Revvity, Inc. | 11.88B | 1.88% | 1,282,327 | 2.86B |
| 16 | ICLR | ICON Public Limited Company | 11.04B | -6.48% | 1,514,764 | 8.10B |
| 17 | QGEN | Qiagen N.V. | 10.53B | 0.59% | 2,253,172 | 2.09B |
| 18 | CRL | Charles River Laboratories International, Inc. | 8.92B | -2.40% | 1,048,610 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.42B | 1.33% | 383,245 | 1.97B |
| 20 | SHC | Sotera Health Company | 4.96B | 0.34% | 1,186,446 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 4.21B | -0.51% | 216,286 | 254.14M |
| 22 | GRAL | GRAIL, Inc. | 4.04B | 3.27% | 622,974 | 141.83M |
| 23 | TWST | Twist Bioscience Corporation | 3.01B | 3.35% | 1,017,058 | 391.56M |
| 24 | VCYT | Veracyte, Inc. | 2.93B | 0.82% | 812,098 | 495.14M |
| 25 | WGS | GeneDx Holdings Corp. | 2.74B | 3.88% | 887,439 | 402.19M |
| 26 | NEOG | Neogen Corporation | 2.33B | 1.13% | 2,494,552 | 880.32M |
| 27 | NEO | NeoGenomics, Inc. | 1.49B | 1.32% | 1,628,451 | 709.16M |
| 28 | CDNA | CareDx, Inc. | 1.06B | 1.88% | 579,480 | 358.00M |
| 29 | CSTL | Castle Biosciences, Inc. | 944.84M | 0.43% | 307,909 | 343.53M |
| 30 | OPK | OPKO Health, Inc. | 936.60M | - | 1,443,105 | 642.07M |
| 31 | PSNL | Personalis, Inc. | 765.49M | 10.09% | 1,924,421 | 69.10M |
| 32 | FLGT | Fulgent Genetics, Inc. | 712.84M | 0.48% | 193,135 | 315.55M |
| 33 | MYGN | Myriad Genetics, Inc. | 473.53M | 0.20% | 830,135 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 360.63M | 1.47% | 402,974 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 333.76M | 1.01% | 2,935 | 75.75M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 212.40M | 3.78% | 29,079 | 4.40M |
| 37 | MDXH | MDxHealth SA | 179.18M | -0.82% | 68,898 | 103.07M |
| 38 | FONR | FONAR Corporation | 122.57M | - | 120,547 | 105.43M |
| 39 | BDSX | Biodesix, Inc. | 82.34M | 4.23% | 120,847 | 80.17M |
| 40 | XGN | Exagen Inc. | 79.32M | 3.86% | 404,352 | 63.60M |
| 41 | PRPO | Precipio, Inc. | 35.93M | 3.59% | 26,795 | 22.80M |
| 42 | MBAI | Check-Cap Ltd. | 12.32M | -3.43% | 78,775 | - |
| 43 | NOTV | Inotiv, Inc. | 11.45M | -7.89% | 679,724 | 513.02M |
| 44 | MYNZ | Mainz Biomed N.V. | 7.97M | 1.71% | 127,620 | 659.94K |
| 45 | ADVB | Advanced Biomed Inc. | 6.29M | 3.29% | 875 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 4.54M | 12.22% | 147,526 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 4.35M | -1.84% | 6,521 | - |
| 48 | ISPC | iSpecimen Inc. | 3.15M | -2.01% | 503,031 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 2.07M | -8.24% | 453,854 | 29.52M |